Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD: Case 2
Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD
Case Scenario 2:
SR is a 58 year-old female, former smoker 20 PPY (stopped smoking 5 years ago), presents with cough and SOB. She experienced an unintended 10 lb weight loss over a 3-month period.
- Tissue analysis identified adenocarcinoma, EGFR, ALK, ROS1 negative.
- PD-L1 expression was < 50%.
- Patient has stage IV disease with metastasis to the liver.
- A chest CT scan confirmed the primary mass in the upper lobe of the right lung, with several pleural metastases and malignant pleural effusion.
- MRI of the brain was negative for intracranial metastases.
- Patient has not complained of blood in the sputum.
- Patient has history of well controlled HTN.
- Her performance status was 1 at diagnosis.
Patient was started on carboplatin/paclitaxel/bevacizumab for 4 cycles. Patient showed partial response and was continued on bevacizumab until progression.
Related Videos
Related Content
FDA Grants Breakthrough Therapy Designation to Sunvozertinib in EGFR Exon20+ NSCLC
April 9th 2024Article
Sunvozertinib was granted breakthrough therapy designation by the FDA for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer harboring an EGFR exon 20 insertion mutation.
Read More
